Balaxi Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 666.6 million compared to INR 138.4145 million a year ago. Net income was INR 109.6 million compared to INR 24.7385 million a year ago. Basic earnings per share from continuing operations was INR 10.96 compared to INR 2.47 a year ago. For the nine months, total revenue was INR 1,821.3 million compared to INR 355.651 million a year ago. Net income was INR 297.8 million compared to INR 46.46 million a year ago. Basic earnings per share from continuing operations was INR 29.78 compared to INR 4.65 a year ago.